Colorectal cancer: preoperative evaluation and staging

NN Mahmoud - Surgical Oncology Clinics, 2022 - surgonc.theclinics.com
Colorectal cancer is a widespread clinical entity—affecting more than 1 million individuals
globally on an annual basis. 1–3 Colorectal cancer remains the third most common nonskin …

Personalized management of elderly patients with rectal cancer: expert recommendations of the European Society of Surgical Oncology, European Society of …

I Montroni, G Ugolini, NM Saur, A Spinelli… - European Journal of …, 2018 - Elsevier
With an expanding elderly population and median rectal cancer detection age of 70 years,
the prevalence of rectal cancer in elderly patients is increasing. Management is based on …

Transanal total mesorectal excision for rectal cancer has been suspended in Norway

HH Wasmuth, AE Faerden, TÅ Myklebust… - Journal of British …, 2020 - academic.oup.com
Background Transanal total mesorectal excision (TaTME) for rectal cancer has emerged as
an alternative to the traditional abdominal approach. However, concerns have been raised …

Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation

SE Oostendorp, HJ Belgers, BT Bootsma… - Journal of British …, 2020 - academic.oup.com
Background Transanal total mesorectal excision (TaTME) has been proposed as an
approach in patients with mid and low rectal cancer. The TaTME procedure has been …

Urethral injury and other urologic injuries during transanal total mesorectal excision: an international collaborative study

P Sylla, JJ Knol, AP D'Andrea, RO Perez… - Annals of …, 2021 - journals.lww.com
Objective: To identify risk factors for urethral and urologic injuries during transanal total
mesorectal excision (taTME) and evaluate outcomes. Background: Urethral injury is a rare …

Long-term oncological results after transanal total mesorectal excision for rectal carcinoma

JC Hol, SE van Oostendorp, JB Tuynman… - Techniques in …, 2019 - Springer
Background Transanal total mesorectal excision (TaTME) for mid and low rectal cancer has
been shown to improve short-term outcomes, mostly due to lower conversion rates and with …

The learning curve of TaTME for mid-low rectal cancer: a comprehensive analysis from a five-year institutional experience

R Persiani, A Agnes, F Belia, D D'Ugo, A Biondi - Surgical endoscopy, 2021 - Springer
Background Transanal total mesorectal excision (TaTME) was introduced in 2009 as a
dedicated approach for the treatment of mid-low rectal cancer. We aimed to describe and …

Recent updates in the surgical treatment of colorectal cancer

T Matsuda, K Yamashita, H Hasegawa… - Annals of …, 2018 - Wiley Online Library
Because of recent advances in medical technology and new findings of clinical trials,
treatment options for colorectal cancer are evolutionally changing, even in the last few years …

Structured training pathway and proctoring; multicenter results of the implementation of transanal total mesorectal excision (TaTME) in the Netherlands

M Veltcamp Helbach, SE van Oostendorp… - Surgical …, 2020 - Springer
Background Transanal total mesorectal excision (TaTME) is a new complex technique with
potential to improve the quality of surgical mesorectal excision for patients with mid and low …

Transanal total mesorectal excision (TaTME): current status and future perspectives

A Vignali, U Elmore, M Milone, R Rosati - Updates in surgery, 2019 - Springer
Total mesorectal excision (TME) is the gold standard surgical treatment for mid-and low
rectal cancer; however, it is associated with specific technical hurdles. Transanal TME …